TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic TumorsBrandon D. Lawrence, Jonathan A. Fletcher, Antonio R. Pérez‐Atayde et al.|American Journal Of Pathology|2000Cited by 716
KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal TumorsMarcia L. Lux, Jonathan A. Fletcher, Brian P. Rubin et al.|American Journal Of Pathology|2000Cited by 647
Prognostic Value of<i>KIT</i>Mutation Type, Mitotic Activity, and Histologic Subtype in Gastrointestinal Stromal TumorsSamuel Singer, Jonathan A. Fletcher, Brian P. Rubin et al.|Journal of Clinical Oncology|2002Cited by 425
Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical TrialsPiotr Rutkowski, Scott M. Schuetze, Allan T. van Oosterom et al.|Journal of Clinical Oncology|2010Cited by 401
Identification of a Disease-Defining Gene Fusion in Epithelioid HemangioendotheliomaMunir R. Tanas, Brian P. Rubin, Andrea Sboner et al.|Science Translational Medicine|2011Cited by 401